Skip to main content
GutCited

Curcumin 用于 肠易激综合征(IBS)

C 证据 来自小型研究的证据有限,但存在一些积极信号。

Small RCTs suggest improvement in IBS symptoms. Anti-inflammatory mechanism plausible but evidence insufficient for strong recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

结论

Small RCTs suggest improvement in IBS symptoms. Anti-inflammatory mechanism plausible but evidence insufficient for strong recommendation.

Key Study Findings

Review
Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Dose: None vs: None Outcome: None 效果: None None

研究人群: patients with IBS (review of plant extracts including peppermint oil, Iberogast, curcumin)

Review
Curcumin in Inflammatory Complications: Therapeutic Applications and Clinical Evidence.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Review of curcumin in inflammatory complications

Systematic Review n=1123 Double-blind
Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic …
Dose: None vs: Placebo/control Outcome: Depression and anxiety in chronic diseases 效果: SMD -0.65 [-1.16, -0.13] depression; SMD -0.22 [-0 0.01 (both)

研究人群: Adults with chronic diseases and depression/anxiety (15 RCTs)

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None vs: Various Outcome: IBS symptom improvement 效果: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

研究人群: Adult IBS patients

Review
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Review of herbal remedies for IBS

Systematic Review
A systematic review of the efficacy and safety of turmeric in the treatment of digestive …
Dose: None vs: None Outcome: None 效果: None None

研究人群: IBS patients

Key Statistics

2

研究数量

200

受试者

↑

Positive

C

等级

Referenced Papers

The American journal … 2019 15 次引用
Current gastroenterology reports 2017 16 次引用
The Medical clinics … 2017 9 次引用
Current gastroenterology reports 2016 30 次引用
Molecular nutrition & … 2013 395 次引用
Indian journal of … 2010 14 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
500-1,500 mg/day with piperine (black pepper extract) for absorption
ibssupport:
500-1,000 mg/day
ucmaintenance:
2,000 mg/day (1 g twice daily) as adjunct to mesalamine

上限: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)

研究中使用的剂量

剂量 持续时间 效果 N
None -- Mixed --
None -- Mixed --
None -- Positive 1123
None -- Positive --
None -- Mixed --
None -- Neutral --
Peppermint oil, STW-5, psyllium, others -- Positive --
200 mg 8 weeks Positive --

最佳服用时间: With meals containing fat and black pepper for enhanced absorption

Safety & Side Effects

已报告的副作用

  • ⚠ GI discomfort (nausea, diarrhea, abdominal pain) at high doses
  • ⚠ Yellow staining of skin/teeth with topical/oral contact
  • ⚠ Increased gallbladder contractions (avoid with gallstones or bile duct obstruction)
  • ⚠ Iron chelation (may reduce iron absorption at very high doses)

已知相互作用

  • ● Anticoagulants (curcumin has antiplatelet properties; may increase bleeding risk)
  • ● Chemotherapy agents (curcumin may alter drug metabolism via CYP enzyme inhibition)
  • ● Sulfasalazine (additive anti-inflammatory effect — may be beneficial in IBD)
  • ● Iron supplements (curcumin may chelate iron; space dosing)
  • ● Piperine/black pepper (enhances curcumin bioavailability by 2,000% — commonly co-administered)

可耐受最高摄入量: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Curcumin help with 肠易激综合征(IBS)?
Based on 2 studies with 200 participants, there is limited but promising evidence that Curcumin may support 肠易激综合征(IBS) management. Our evidence grade is C (Some Evidence).
How much Curcumin should I take for 肠易激综合征(IBS)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day with piperine (black pepper extract) for absorption. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include GI discomfort (nausea, diarrhea, abdominal pain) at high doses, Yellow staining of skin/teeth with topical/oral contact, Increased gallbladder contractions (avoid with gallstones or bile duct obstruction), Iron chelation (may reduce iron absorption at very high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and 肠易激综合征(IBS)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

References

  1. [1] Ploutarchos Pastras et al.. Nutrients. 2026. Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines. doi:10.3390/nu18020183 PubMed
  2. [2] Sheida Zeraattalab-Motlagh et al.. Nutr Rev. 2025. Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical … doi:10.1093/nutrit/nuae107 PubMed
  3. [3] Jiyuan Yuan et al.. Front Pharmacol. 2025. Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical … doi:10.3389/fphar.2025.1638645 PubMed
  4. [4] Amber Zafar et al.. Int J Mol Sci. 2025. Curcumin in Inflammatory Complications: Therapeutic Applications and Clinical Evidence. doi:10.3390/ijms26199366 PubMed
  5. [5] Raquel Abalo et al.. Int J Mol Sci. 2025. Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies. doi:10.3390/ijms26199345 PubMed
  6. [6] Kednapa Thavorn et al.. Phytother Res. 2024. A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders. doi:10.1002/ptr.8189 PubMed
  7. [7] Ursula Wade et al.. Nutrients. 2024. The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel … doi:10.3390/nu16081204 PubMed
  8. [8] Sandra Utz et al.. Z Gastroenterol. 2024. [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review]. doi:10.1055/a-2279-5045 PubMed
  9. [9] Sagarika Majhi et al.. CNS Neurol Disord Drug Targets. 2023. A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions. doi:10.2174/1871527321666220428134802 PubMed
  10. [10] Xiaoting Tu et al.. Front Microbiol. 2023. Therapeutic effects of curcumin on constipation-predominant irritable bowel syndrome is associated with modulating gut microbiota and neurotransmitters. doi:10.3389/fmicb.2023.1274559 PubMed
  11. [11] Ludovic D Langlois et al.. Int J Mol Sci. 2023. Effects of Glutamine, Curcumin and Fish Bioactive Peptides Alone or in Combination on Intestinal Permeability in a Chronic-Restraint Stress Model. doi:10.3390/ijms24087220 PubMed
  12. [12] Attilio Giacosa et al.. Nutrients. 2022. Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with … doi:10.3390/nu14030416 PubMed
  13. [13] Emad Jafarzadeh et al.. Iran J Public Health. 2022. Turmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence. doi:10.18502/ijph.v51i6.9656 PubMed
  14. [14] Hui-Fang Chiu et al.. Molecules. 2021. Gastroprotective Effects of Polyphenols against Various Gastro-Intestinal Disorders: A Mini-Review with Special Focus on Clinical Evidence. doi:10.3390/molecules26072090 PubMed
  15. [15] Adrian L Lopresti et al.. BMC Complement Med Ther. 2021. Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, … doi:10.1186/s12906-021-03220-6 PubMed
  16. [16] Masoumeh Atefi et al.. Adv Exp Med Biol. 2021. A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases. doi:10.1007/978-3-030-56153-6_18 PubMed
  17. [17] Karin Ried et al.. Nutr Res. 2020. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. doi:10.1016/j.nutres.2020.02.008 PubMed
  18. [18] Jason A Hawrelak et al.. Complement Ther Med. 2020. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. doi:10.1016/j.ctim.2019.102233 PubMed
  19. [19] Timo A Thumann et al.. J Ethnopharmacol. 2019. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders. doi:10.1016/j.jep.2019.112153 PubMed
  20. [20] Sandra M Quezada et al.. Curr Gastroenterol Rep. 2019. Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases. doi:10.1007/s11894-019-0670-0 PubMed
  21. [21] Afrin Kamal et al.. Am J Gastroenterol. 2019. Influence of Dietary Restriction on Irritable Bowel Syndrome. doi:10.1038/s41395-018-0241-2 PubMed
  22. [22] Laura Appleton et al.. J Clin Med. 2019. Re: A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome. doi:10.3390/jcm8111885 PubMed
  23. [23] Qin Xiang Ng et al.. J Clin Med. 2018. A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS). doi:10.3390/jcm7100298 PubMed
  24. [24] Agostino Di Ciaula et al.. Ann Gastroenterol. 2018. Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel … doi:10.20524/aog.2018.0304 PubMed
  25. [25] Islam Khan et al.. Med Princ Pract. 2017. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal. doi:10.1159/000468988 PubMed
  26. [26] Felix Alt et al.. Phytother Res. 2017. Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled … doi:10.1002/ptr.5826 PubMed
  27. [27] Brent W Acker et al.. Curr Gastroenterol Rep. 2017. Medicinal Foods for Functional GI Disorders. doi:10.1007/s11894-017-0601-x PubMed
  28. [28] Joshua Korzenik et al.. Med Clin North Am. 2017. Complementary and Integrative Gastroenterology. doi:10.1016/j.mcna.2017.04.009 PubMed
  29. [29] Piero Portincasa et al.. J Gastrointestin Liver Dis. 2016. Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. doi:10.15403/jgld.2014.1121.252.ccm PubMed
  30. [30] Tanisa Patcharatrakul et al.. Curr Gastroenterol Rep. 2016. Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and Disease. doi:10.1007/s11894-016-0494-0 PubMed
  31. [31] Yingcong Yu et al.. Metab Brain Dis. 2015. The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. doi:10.1007/s11011-014-9554-z PubMed
  32. [32] V I Pilipenko et al.. Vopr Pitan. 2015. [Dry jelly concentrate with vitamins and dietary fiber in patients with IBS with constipation: a comparative controlled study]. PubMed
  33. [33] Subash C Gupta et al.. AAPS J. 2013. Therapeutic roles of curcumin: lessons learned from clinical trials. doi:10.1208/s12248-012-9432-8 PubMed
  34. [34] Subash C Gupta et al.. Mol Nutr Food Res. 2013. Multitargeting by turmeric, the golden spice: From kitchen to clinic. doi:10.1002/mnfr.201100741 PubMed
  35. [35] V I Pilipenko et al.. Vopr Pitan. 2013. [Contemporary dietotherapy of the irritable bowel syndrome]. PubMed
  36. [36] Jean Robert Rapin et al.. Clinics (Sao Paulo). 2010. Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine. doi:10.1590/S1807-59322010000600012 PubMed
  37. [37] Anil Kumar et al.. Indian J Physiol Pharmacol. 2010. Effects of curcumin on the intestinal motility of albino rats. PubMed
  38. [38] D G Binion et al.. Gut. 2008. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. doi:10.1136/gut.2008.152496 PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。